Answers are grounded in this paper and cite their sources.
Introduces percutaneous transluminal septal myocardial ablation as a treatment for hypertrophic obstructive cardiomyopathy.
H. Seggewiss; Percutaneous transluminal septal myocardial ablation: A new treatment for hypertrophic obstructive cardiomyopathy, European Heart Journal, Volume
No takes yet. Share an insight, caveat, or question.
Hubert Seggewiß (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: